Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

Autoimmune Diseases · Rheumatoid Arthritis (RA) · Psoriatic Arthritis (PsA) · Psoriasis (PsO) · Cutaneous Lupus Erythematosus (CLE) · Atopic Dermatitis (AD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Novatrials, Charlestown, New South Wales, Australia
Contact: Study coordinator (Toni McCallum Pardey) · toni@novatrials.com.au · +61 (02) 4089 3746
University of the Sunshine Coast Clinical Trials, Birtinya, Birtinya, Queensland, Australia
Contact: Study coordinator (Peter de Wet, MD) · ctcvitality@usc.edu.au · +61 (07) 5456 3872

Study leads

Jennifer Martin, MD
Principal Investigator
Novatrials

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

Autoimmune

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia

MAD Study of IA-14069

Healthy · Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1

Lenexa, United States

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Refractory Autoimmune Diseases

IsraelRecruitingPHASE1

Boston, United States · Durham, United States